{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=AIMS&page=56", "query": { "intervention": "AIMS", "page": 56 }, "page_size": 10 }, "pagination": { "page": 56, "page_size": 10, "total_count": 1728, "total_pages": 173, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=AIMS&page=57&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=AIMS&page=55&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T04:36:56.782Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01853202", "title": "EXercise Training for the Prevention of Cancer Thrombosis (EXPECT) Pilot Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cancer Thrombosis" ], "interventions": [ { "name": "Supervised aerobic exercise training", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Vermont", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "18 Years to 79 Years" }, "enrollment_count": 40, "start_date": "2013-03", "completion_date": null, "has_results": false, "last_update_posted_date": "2014-12-04", "last_synced_at": "2026-11-15T04:36:56.782Z", "location_count": 1, "location_summary": "Burlington, Vermont", "locations": [ { "city": "Burlington", "state": "Vermont" } ], "official_url": "https://clinicaltrials.gov/study/NCT01853202" }, { "nct_id": "NCT07559253", "title": "Implementation of an Accessible Healthcare Model (ACHD STRONG): Comparing Nurse and Physician Lead Healthcare Transition Education in a RE-AIM Framework", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Congenital Heart Disease" ], "interventions": [ { "name": "Accessible Care Model Visit", "type": "OTHER" }, { "name": "Recruitment Interviews", "type": "OTHER" }, { "name": "Participating Patient-Support Person Interviews", "type": "OTHER" }, { "name": "Participating Patient-Support Person Surveys", "type": "OTHER" }, { "name": "Participating Provider Interviews and surveys", "type": "OTHER" }, { "name": "Unstructured and semi-structured interviews", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "26 Years", "sex": "ALL", "summary": "12 Years to 26 Years" }, "enrollment_count": 450, "start_date": "2025-12-01", "completion_date": "2026-11-30", "has_results": false, "last_update_posted_date": "2026-05-05", "last_synced_at": "2026-11-15T04:36:56.782Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT07559253" }, { "nct_id": "NCT06266494", "title": "Prevention and Treatment of Frostbite Infection With Antimicrobial Pharmacokinetic Analysis", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Frostbite" ], "interventions": [ { "name": "Long-Acting silver dressings", "type": "DEVICE" }, { "name": "Aloe Vera", "type": "OTHER" }, { "name": "Dalbavancin", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "OTHER", "DRUG" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 100, "start_date": "2024-03-01", "completion_date": "2026-08", "has_results": false, "last_update_posted_date": "2024-05-13", "last_synced_at": "2026-11-15T04:36:56.782Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT06266494" }, { "nct_id": "NCT04188041", "title": "Improving Rhode Island's Tuberculosis Preventive Services in Primary Care", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Latent Tuberculosis" ], "interventions": [ { "name": "TB Infection ECHO", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Kent Hospital, Rhode Island", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 84, "start_date": "2019-10-02", "completion_date": "2022-07-31", "has_results": true, "last_update_posted_date": "2024-07-19", "last_synced_at": "2026-11-15T04:36:56.782Z", "location_count": 1, "location_summary": "Pawtucket, Rhode Island", "locations": [ { "city": "Pawtucket", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT04188041" }, { "nct_id": "NCT04800588", "title": "Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Alzheimer Disease", "Cognitive Decline", "Aging" ], "interventions": [ { "name": "California Cognitive Assessment Battery", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Neurobehavioral Systems, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "18 Years to 89 Years" }, "enrollment_count": 2000, "start_date": "2021-05-05", "completion_date": "2027-03-31", "has_results": false, "last_update_posted_date": "2026-11-13", "last_synced_at": "2026-11-15T04:36:56.782Z", "location_count": 1, "location_summary": "Berkeley, California", "locations": [ { "city": "Berkeley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04800588" }, { "nct_id": "NCT04743661", "title": "131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Recurrent Medulloblastoma", "Recurrent Ependymoma" ], "interventions": [ { "name": "Irinotecan", "type": "DRUG" }, { "name": "Temozolomide", "type": "DRUG" }, { "name": "Bevacizumab", "type": "DRUG" }, { "name": "Omburtamab I-131", "type": "DRUG" }, { "name": "Liothyronine", "type": "DRUG" }, { "name": "SSKI", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Antipyretic", "type": "DRUG" }, { "name": "Antihistamine", "type": "DRUG" }, { "name": "anti-emetics", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pediatric Brain Tumor Consortium", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 62, "start_date": "2022-04-04", "completion_date": "2027-09-30", "has_results": false, "last_update_posted_date": "2026-07-28", "last_synced_at": "2026-11-15T04:36:56.782Z", "location_count": 3, "location_summary": "Los Angeles, California • New York, New York • Cincinnati, Ohio", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "New York", "state": "New York" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04743661" }, { "nct_id": "NCT00428805", "title": "Child Health Initiative for Lifelong Eating and Exercise (CHILE)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "classroom curriculum", "type": "BEHAVIORAL" }, { "name": "In-service training for Head Start teachers/aides", "type": "BEHAVIORAL" }, { "name": "Training for Head Start food service", "type": "BEHAVIORAL" }, { "name": "Family intervention component", "type": "BEHAVIORAL" }, { "name": "Food source", "type": "BEHAVIORAL" }, { "name": "Health care providers", "type": "BEHAVIORAL" }, { "name": "CHILE Head Start Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of New Mexico", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "3 Years", "maximum_age": "5 Years", "sex": "ALL", "summary": "3 Years to 5 Years" }, "enrollment_count": 980, "start_date": "2006-03", "completion_date": "2010-06", "has_results": false, "last_update_posted_date": "2024-03-05", "last_synced_at": "2026-11-15T04:36:56.782Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT00428805" }, { "nct_id": "NCT05437705", "title": "Decoding and Modulating Affective Brain States", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Rumination", "Major Depressive Disorder", "Anxiety" ], "interventions": [ { "name": "Transcranial Magnetic Stimulation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 40, "start_date": "2023-02-21", "completion_date": "2029-12-01", "has_results": false, "last_update_posted_date": "2026-09-03", "last_synced_at": "2026-11-15T04:36:56.782Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05437705" }, { "nct_id": "NCT00663754", "title": "Effectiveness of a Dissonance-Based Eating Disorder Prevention Program (The Body Project II)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Eating Disorders" ], "interventions": [ { "name": "Dissonance-based eating disorder prevention program", "type": "BEHAVIORAL" }, { "name": "Educational brochure", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Oregon Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "14 Years", "maximum_age": "18 Years", "sex": "FEMALE", "summary": "14 Years to 18 Years · Female only" }, "enrollment_count": 306, "start_date": "2005-03", "completion_date": "2012-10", "has_results": false, "last_update_posted_date": "2014-03-04", "last_synced_at": "2026-11-15T04:36:56.782Z", "location_count": 1, "location_summary": "Eugene, Oregon", "locations": [ { "city": "Eugene", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00663754" }, { "nct_id": "NCT03816345", "title": "Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Autoimmune Disease", "Crohn Disease", "Dermatomyositis", "Hematopoietic and Lymphoid Cell Neoplasm", "Inflammatory Bowel Disease", "Malignant Solid Neoplasm", "Multiple Sclerosis", "Psoriasis", "Psoriatic Arthritis", "Rheumatoid Arthritis", "Sjogren Syndrome", "Systemic Lupus Erythematosus", "Systemic Scleroderma", "Ulcerative Colitis" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Cabozantinib", "type": "DRUG" }, { "name": "Fluoropyrimidine", "type": "DRUG" }, { "name": "Ipilimumab", "type": "BIOLOGICAL" }, { "name": "Nivolumab", "type": "BIOLOGICAL" }, { "name": "Platinum Compound", "type": "DRUG" }, { "name": "Platinum Doublet", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG", "BIOLOGICAL" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2019-07-16", "completion_date": "2028-03-30", "has_results": false, "last_update_posted_date": "2026-11-12", "last_synced_at": "2026-11-15T04:36:56.782Z", "location_count": 51, "location_summary": "Birmingham, Alabama • Palo Alto, California • Sacramento, California + 37 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Palo Alto", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03816345" } ] }